Literature DB >> 16000611

Surgical management of T3 and T4 lung cancer.

Costanzo A DiPerna1, Douglas E Wood.   

Abstract

Locally advanced lung cancer (T(3) or T(4)) has a significantly worse prognosis than lower stage disease. However, this diagnosis is usually made radiologically, and experienced thoracic surgeons are familiar with the low radiologic to pathologic correlation in tumors that abut the great vessels, mediastinum, or chest wall. Commonly these tumors do not directly invade adjacent structures and are, in fact, T(1) or T(2) tumors that are resectable through standard techniques. Where there is no clearly evident invasion of unresectable structures, the patient should be given the benefit of the doubt and considered at a lower (resectable) stage until proven otherwise. The curability of T(3) tumors varies according to the involved site. A T(3)N(0) tumor involving the chest wall provides the most favorable prognosis among the resected T(3) lesions, with a 5-year survival of >50% in lymph node-negative patients if resection is complete. Palliative incomplete resections of T(4) disease, in which tumor has invaded mediastinal structures, have not shown any survival benefit and are associated with very high morbidity and mortality. However, patients with limited invasion of the carina, left atrium, superior vena cava, or pulmonary artery may be able to be completely resected despite their T(4) classification. Surgical resection remains an important part of the therapy for patients with locally advanced lung cancer. Modern techniques of chest wall resection and reconstruction and bronchoplastic procedures allow complete resection of locally advanced tumors with favorable 5-year survival rates and low morbidity and mortality.

Entities:  

Mesh:

Year:  2005        PMID: 16000611     DOI: 10.1158/1078-0432.CCR-05-9007

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

2.  Chest wall/parietal pleural invasions worsen prognosis in T4 non-small cell lung cancer patients after resection.

Authors:  Hiroshi Yabuki; Akira Sakurada; Shunsuke Eba; Fumihiko Hoshi; Hisashi Oishi; Yasushi Matsuda; Tetsu Sado; Masafumi Noda; Yoshinori Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-21

Review 3.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

4.  [Interdisciplinary treatment of non-small cell lung cancer].

Authors:  J Dunst; C Kugler; D Ukena
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

5.  Management and surgical resection for tumors of the trachea and carina: experience with 32 patients.

Authors:  Xiang-Yan Liu; Fan-Ying Liu; Zhou Wang; Gang Chen
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  Stereotactic radiotherapy for the treatment of lung cancer with a giant left atrial tumor thrombus: A case report and literature review.

Authors:  Yong Li; Jinrong Lou; Shujun Qiu; Yutian Guo; Mianshun Pan
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

7.  Surgical treatment of lung cancer invading the left atrium or base of the pulmonary vein.

Authors:  Lihui Wu; Zhifei Xu; Xuewei Zhao; Jianqiu Li; Lei Zhong; Tieweng Pang; Bin Wu
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

8.  Factors predicting the surgical outcome in patients with T3/4 lung cancer.

Authors:  Hidetaka Uramoto; Hidehiko Shimokawa; Takeshi Hanagiri; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  Surg Today       Date:  2014-02-16       Impact factor: 2.549

Review 9.  Surgical strategies in the therapy of non-small cell lung cancer.

Authors:  Feras Al-Shahrabani; Daniel Vallböhmer; Sebastian Angenendt; Wolfram T Knoefel
Journal:  World J Clin Oncol       Date:  2014-10-10

10.  Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Katsuyuki Kiura; Keitaro Matsuo; Junichi Soh; Masaomi Yamane; Takahiro Oto; Mitsuhiro Takemoto; Hiroshi Date; Shinichiro Miyoshi
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.